Stocks To Watch For Monday 02/24/14 – NVLX BIEL HLNT


Hi Everyone & Welcome New Subscribers,

We hope all of you have had a nice weekend, and enjoy what’s left of it before U.S. markets open again tomorrow morning. Last week, our most recent pick VAPO surged more than 37.50% from our alert on record volume, but was held back by a unrelenting seller. While we feel the potential for VAPO is strong, considering it’s place in the e-cig/vaporizer industry, it needs remain above .10 and look to push and hold past .20 on positive news from the company (which we have been anticipating and looking for), establishing an uptrend in the stock.

NVLX  Potential Continued Momentum/Volume – (Nuvilex, Inc.) – closed up 29.83%, at .2999 a share, on more than 39.4 million shares traded Friday. Nuvilex, Inc. is an international biotechnology firm focused on developing and preparing to commercialize treatments for cancer and diabetes built on a proprietary cellulose-based live-cell encapsulation platform, known as Cell-in a-Box(TM), that is therapeutically valuable. Just last week, NVLX announced that they had entered into a stock purchase agreement with Lincoln Park Capital Fund, LLC (Lincoln Park), a Chicago-based institutional investor. Lincoln Park initially purchased 8 million shares of Nuvilex’s common stock at $0.25 per share for $2 million and has committed to invest, at the sole option of Nuvilex, up to an additional $25 million of equity capital over the term of the purchase agreement. Read the full story, HEREShares of NVLX surged last week following this news, and for good reason, considering the recent $2M investment at .25, which was below where the stock traded most of the week. It’s possible NVLX starts to establish a floor near this price over the coming days, but after closing just off Friday’s high on all-time record volume, it could be in for one more big day Monday. Keep it on close watch.

BIEL  Potential Continued Momentum/Volume – (BioElectronics Corp.) – closed up a whopping 460.00%, at .0028 a share, on more than 1.2 billion shares traded Friday. BioElectronics Corporation develops, manufactures, markets and sells consumer medical electronic devices that have both a high efficacy and safety profile for acute and chronic pain. Along with the added benefit of an unmatched cost/benefit ratio, the Company’s innovative, miniaturized technology contains an embedded microchip and battery that deliver pulsed electromagnetic field energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that has only been possible to obtain from large, facility-based equipment. BIEL announced Friday, before the market opened, their excitement over the FDA’s recent recla
ssification of shortwave medical devices (which 
BIEL focuses on specifically for drug-free pain relief applications) to class II, which was received extremely well by investors. Read the full press release, HEREBIEL traded a record amount of shares following this news, and closed just below Friday’s high of .003, which it might open over tomorrow. Keep it on close watch for a move higher tomorrow, or over the coming weeks following this volume off what appears to be a price bottom near .001.

HLNT  Potential Continued Momentum/Volume – (Highline Technical Innovations Inc.) – closed up 100.00%, at .0018 a share, on more than 133.5 million shares traded FridayHighline Technical Innovations Inc. (HLNT) is based in Sprindale, Arkansas. HTI is dedicated to producing innovative, high quality products that are economical and reduce environmental impact. HLNT also had some exciting news to announce Friday, which was also received extremely well by the investment community, and led to a record volume day too. HLNT established a relationship with the U.S. Army, whereby the Department of Defense (DoD) will fund their Hy-Impact hydrogen unit. Read more, HERE. Shares closed not far off Friday’s high of .0024, and with this strong of news may continue higher tomorrow and over the next several weeks. Keep it on watch tomorrow for continued momentum, or a potential buy on the dip over the next few days.

New Profiled Pick Coming Soon: Most Recent Pick Surged Nearly 40% From Our Alert On Record Volume! 

Sign Up-> HERE <-To Be Among The First To Receive Our Next Winning Pick!

Happy Trading!

The Penny Stock Experts Team at

Follow us on Twitter @Todayspickis

Please read our legal Disclaimer below:

This disclaimer is to be read in its entirety, and fully understood before using or joining the email list. reserves the right to revise, amend, or modify our Privacy Policy, our Disclaimer, and our other policies and agreements at any time and in any manner by updating their postings. You are responsible for regularly reviewing these terms, conditions, and notices, and any additional terms posted on Your continued use of the website and/or email newsletter after the effective date of such changes constitutes your acceptance of and agreement to such changes. If we should update this disclaimer, we will post the updates to this page on

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE OR IN ONE OF OUR NEWSLETTERS.Neither nor any of its employees, affiliates, subsidiaries, or family members are registered investment advisers or registered stock brokers either within the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of, or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site. We are neither licensed nor qualified to provide investment advice.

The information contained on our website or in any of our newsletters should be viewed as commercial advertisement and is not intended to be investment advice. Any information found on our website, or in any of our newsletters is not provided to any particular individual with a view toward their individual circumstances. The information contained on our website, and in any newsletter we distribute, is not an offer to buy or sell securities. We distribute opinions, comments, and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our newsletter or website. Individuals should assume that all information contained on our website or in one of our newsletters about profiled companies is not trustworthy unless verified by their own independent research. may buy or sell shares on the open market that may positively or negatively affect the stock price before or after this mailing and subscribers are to be fully aware that and it’s affiliates can buy or sell more shares at any time. and/or it’s affiliates may receive compensation for e-mail alerts. To view our full compensation disclosure please visit does not accept free-trading shares as a form of payment.